News

The FDA rightfully cracked down on compounding pharmacies under a 2013 law brought on by 64 deaths traced to contaminated drugs at a dirty compounding facility. But physicians are concerned the FDA's new powers could end in-office compounding for individual patients, a common practice in many medical specialities.

osteoporosis

(CCR 2015) A number of new osteoporosis treatments are on the near horizon, drawing on a new understanding of bone biology, as described by a speaker at the Clinical Congress of Rheumatology.

Calcium pyrophosphate deposition disease is many times more common than rheumatoid arthritis, but rarely studied and difficult to diagnose. Here an expert rheumatologist offers the basics for management today and prospects for the future.

A new study suggests the importance of evaluating the vitamin D3 status and screening for comorbid conditions in patients with psoriasis or psoriatic arthritis.

Bone erosions found at a rheumatoid arthritis (RA) patient’s baseline exam are harbingers of future joint damage and more severe disease. As to why this is so, new studies offer only hints.

Dating probably doesn't enter the conversation very often during visits with your lupus patients. Here, someone who has had more than her share of struggles with lupus describes trying to find someone to share that difficult life.

A small prospective study finds that patients with psoriatic arthritis eventually revert to disease if TNF-alpha drugs are discontinued, sometimes as much as 6 months later.

Numbers in randomized drug trials were too small to amass enough adverse events to settle the issue, but combined they show an increased hypertension risk for the tumor necrosis factor inhibitors used to treat rheumatoid arthritis.

A review and a research study take a closer look at the small vessel disease that's generally tied to hepatitis C but may arise in autoimmune disorders. The latter finds new markers for severity.